Vytrus Biotech, S.A.

€13.70As of Sun 8 Nov 2026, 12:00 UTC
BME:VYTHealthcare
Country Spain
PE (Fwd) •••
TSR 5Y CAGR 36.04%
Div yield —
ROE 36.82%
Biotechnology
Beta (5Y) (0.07)
PE TTM 25.56
TSR TTM 101.47%
Mkt cap €103.1M
ROIC 40.37%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€14
5.08%
(3.76%)
Sell 1|1|2|2|4
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.22
0.21
0.22
0.24
9.75%
(2.44%)
2.92%
14.80%
Revenue€M
10.73
11.05
10.80
10.82
2.72%
9.04%
2.83%
1.14%
Peers (US$115.7M)
Cap (US$)
PE
225.9M
—
Capital
TTM
5Y
10Y
Leveragex
2.345
0.417
0.364
EBIT/Intx
0.130
1.247
1.154
Own earn%
(5.45)
26.99
10.91
Sh yield%
13.17
49.55
50.02
Owners
Insiders/Inst%
8.02
80.90
Short interest%
0.83
SBC / revenue%
1.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
27–31
$1 testx
—
Incr. ROIC%
0